What is the 13F Pro Quality Score for RPID?

13F Pro ranks RAPID MICRO BIOSYSTEMS, INC. (RPID) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View RPID's current score at https://13fpro.ai/research/RPID (free sign-up required for the full ranking).

Where does 13F Pro source RPID data?

All RAPID MICRO BIOSYSTEMS, INC. fundamentals and ownership data come directly from SEC EDGAR. RAPID MICRO BIOSYSTEMS, INC. files with the SEC under CIK 1380106. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is RPID in?

RAPID MICRO BIOSYSTEMS, INC. (RPID) is classified in the Technology sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/technology.

How often is RPID research updated on 13F Pro?

RPID's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

RAPID MICRO BIOSYSTEMS, INC.(RPID)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Technology →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1380106 RPID stock profile & AI dashboard →

13F Pro Quality Score

26.2/100

Rank #2,514 of 2,879 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

79.2/100

Profitability

6.0/100

Balance Sheet

2.0/100

Earnings Quality

30.0/100

Free Cash Flow

5.7/100

Institutional Flow

93.0/100

Revenue Scale

7.4/100

Dilution Risk

14.9/100

RPID Stock Analysis & AI Quality Score

AI stock analysis and institutional research for RAPID MICRO BIOSYSTEMS, INC. (RPID), a Technology sector company. 13F Pro's AI-powered ranking engine scores RPID at 26.2/100 on a 32-signal composite quality model, placing it at rank #2,514 of 2,879 stocks — the bottom half of the AI-ranked universe. RPID scores in the top quartile across institutional flow (93.0), revenue growth (79.2). Areas of concern include balance sheet strength (2.0) and free cash flow (5.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), RAPID MICRO BIOSYSTEMS, INC. reports quarterly revenue of $8.0M, net income of $-14.3M, free cash flow of $-15.5M. Top institutional holders of RPID by reported 13-F value include Bain Capital Life Sciences Investors,, ABG-WTT Global Life Science Capital Partners GP Ltd, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. RPID trades on the Nasdaq exchange and files with the SEC under CIK 1380106. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RPID daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for RAPID MICRO BIOSYSTEMS, INC. directly from SEC EDGAR. RAPID MICRO BIOSYSTEMS, INC.'s 13F Pro composite quality score has ranged between 7 and 30 since 2022, currently 26.2 — a declining long-term trajectory across 24 quarterly and live scoring snapshots.

Revenue

Q1 2026

$8.0M

Net Income

Q1 2026

$-14.3M

Free Cash Flow

Q1 2026

$-15.5M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+19.7% YoY

$33.6MFY 2025

FY22 $17.1MFY23 $22.5MFY24 $28.1MFY25 $33.6M

Net Income

-0.5% YoY

$-47.1MFY 2025

FY22 $-60.8MFY23 $-52.5MFY24 $-46.9MFY25 $-47.1M

Operating Income

+5.1% YoY

$-47.4MFY 2025

FY22 $-63.2MFY23 $-56.6MFY24 $-49.9MFY25 $-47.4M

EPS (Diluted)

+2.8% YoY

$-1.05FY 2025

FY22 $-1.43FY23 $-1.22FY24 $-1.08FY25 $-1.05

Total Assets

-23.8% YoY

$74.9MFY 2025

FY22 $190.7MFY23 $143.5MFY24 $98.2MFY25 $74.9M

Total Debt

$18.9MFY 2025

FY22 $0.00FY23 —FY24 $0.00FY25 $18.9M

Op. Cash Flow

+29.6% YoY

$-31.1MFY 2025

FY22 $-58.5MFY23 $-45.1MFY24 $-44.2MFY25 $-31.1M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$33.6M +19.7%	$28.1M +24.6%	$22.5M +31.4%	$17.1M -26.3%	$23.2M +44.5%	$16.1M
Net Income	$-47.1M -0.5%	$-46.9M +10.6%	$-52.5M +13.7%	$-60.8M +17.3%	$-73.5M -98.3%	$-37.1M
Operating Income	$-47.4M +5.1%	$-49.9M +11.7%	$-56.6M +10.5%	$-63.2M -33.8%	$-47.2M -54.7%	$-30.5M
EPS (Diluted)	$-1.05 +2.8%	$-1.08 +11.5%	$-1.22 +14.7%	$-1.43 +63.7%	$-3.94 +96.9%	$-126.11
Total Assets	$74.9M -23.8%	$98.2M -31.6%	$143.5M -24.8%	$190.7M -20.9%	$241.2M +244.5%	$70.0M
Total Debt	$18.9M	$0.00	—	$0.00	$0.00 -100.0%	$24.8M
Operating Cash Flow	$-31.1M +29.6%	$-44.2M +2.1%	$-45.1M +23.0%	$-58.5M -6.5%	$-55.0M -77.3%	$-31.0M

AI Insight: RPID Ratio Trends

RPID remains deeply unprofitable with deteriorating returns; Q1 2026 operating margin collapsed to -173.1% and ROA worsened to -91.6%.

• Operating margin deteriorated from -108.2% in Q4 2025 to -173.1% in Q1 2026, marking the worst quarterly result in the trailing dataset.

• ROA fell from -66.8% in Q4 2025 to -91.6% in Q1 2026, indicating sharply negative asset productivity.

• Net profit margin declined to -178.4% in Q1 2026, the weakest quarterly performance observed.

⚠ Debt-to-equity ratio rose to 0.93 in Q1 2026 from 0.57 in Q4 2025—leverage increased 63% in one quarter.

⚠ No path to profitability evident; all efficiency metrics remain severely negative across all quarters shown.

Get alerted when RPID's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for RAPID MICRO BIOSYSTEMS, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of RPID

Bain Capital Life Sciences Investors, LLC
$19.1M8,434,560 sh
ABG-WTT Global Life Science Capital Partners GP Ltd
$4.2M1,848,296 sh
VANGUARD CAPITAL MANAGEMENT LLC
$2.2M982,494 sh
ESSEX INVESTMENT MANAGEMENT CO LLC
$2.0M883,931 sh
ADVENT INTERNATIONAL, L.P.
$1.3M552,377 sh
Evernest Financial Advisors, LLC
$1.0M432,510 sh
SEI INVESTMENTS CO
$646.5K284,816 sh
MILLENNIUM MANAGEMENT LLC
$643.0K283,280 sh
Legato Capital Management LLC
$624.1K274,924 sh
GEODE CAPITAL MANAGEMENT, LLC
$561.3K247,177 sh

Fund	Value	Shares
Bain Capital Life Sciences Investors, LLC	$19.1M	8,434,560
ABG-WTT Global Life Science Capital Partners GP Ltd	$4.2M	1,848,296
VANGUARD CAPITAL MANAGEMENT LLC	$2.2M	982,494
ESSEX INVESTMENT MANAGEMENT CO LLC	$2.0M	883,931
ADVENT INTERNATIONAL, L.P.	$1.3M	552,377
Evernest Financial Advisors, LLC	$1.0M	432,510
SEI INVESTMENTS CO	$646.5K	284,816
MILLENNIUM MANAGEMENT LLC	$643.0K	283,280
Legato Capital Management LLC	$624.1K	274,924
GEODE CAPITAL MANAGEMENT, LLC	$561.3K	247,177

More Technology Companies

View all Technology →

AGILENT TECHNOLOGIES, INC.

AAOI

APPLIED OPTOELECTRONICS, INC.

AAPL

Apple Inc.

ABNB

Airbnb, Inc.

ACCL

Acco Group Holdings Ltd

ACCS

ACCESS Newswire Inc.

ACFN

ACORN ENERGY, INC.

ACIW

ACI WORLDWIDE, INC.

Put RPID on your watchlist

Track score changes the day RAPID MICRO BIOSYSTEMS, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is RPID a good stock to buy?

13F Pro's AI-powered analysis of RAPID MICRO BIOSYSTEMS, INC. (RPID) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for RPID are available on the RPID stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own RPID?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling RPID. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of RAPID MICRO BIOSYSTEMS, INC.'s investment landscape.